LabCompass

Steven P. Angus

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1999Rising activity
Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsMeningioma and schwannoma managementSarcoma Diagnosis and TreatmentMelanoma and MAPK Pathways

Publications

573

Citations

2,771

Est. group size

~2

Recurring co-author estimate

Active years

28

Publishing since 1999

Research summary
AI-generated

Steven P. Angus studies cancer biology with a focus on how tumors respond to targeted drug treatments, particularly cancers driven by faulty cell-signaling pathways (such as those involving RAS and MEK proteins). Much of the work explores combination therapies and drug-resistance mechanisms in pediatric and other cancers including rhabdomyosarcoma, leukemia, osteosarcoma, and sarcomas. The research aims to identify drug combinations that shrink tumors or make cancer cells more vulnerable to treatment.

Targeted cancer drug therapiesCell-signaling pathways (RAS/MEK/MAPK)Pediatric cancers (sarcoma, rhabdomyosarcoma)Leukemia treatment strategiesDrug combinations and synthetic lethality

Publication output was modest and steady from 2017 to 2022 (roughly 4-12 per year), then sharply increased from 2023 onward, likely reflecting a change in output or record-keeping.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through January 2028 — about 1 year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH R01NS129769through Jan 2028 · $449k awarded

    Identification of novel therapeutic combinations for NF2 schwannomas

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 5,073 established Medicine PIs within our index
Citations: 2,771cohort median 2,525
h-index: 31cohort median 24
Publications / year (recent): 98.2cohort median 4.8

Typically publishes in teams of ~15 · 1% small-team papers (≤3 authors) · across 37 venues

Publication cadence
Publications per year over the last 10 years — averaging 98.2/year recently
2017: 9 publications172018: 10 publications182019: 11 publications192020: 12 publications202021: 9 publications212022: 4 publications222023: 153 publications232024: 175 publications175242025: 95 publications252026: 64 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 2 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 9 collaborators at the same institution2024: 8 collaborators at the same institution2025: 1 collaborator at the same institution1719212325
Recent publications
Publishes in
  • Cancer Research×17
  • UNC Libraries×14
  • Neuro-Oncology×13
  • bioRxiv (Cold Spring Harbor Laboratory)×5
  • Clinical Cancer Research×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile